Optimizing Dosing Strategies in Oral Iron Supplementation

Exclusion Criteria

• •Refusal of study participation,
• •Regular administration of Erythropoietin
• •Oral or intravenous iron supplementation \<12 weeks prior to investigation
• •Contraindications to intervention medication (Tardyferon), e.g. known hypersensitivity or allergy to iron sulfate / ferrous sulfate
• •Blood transfusion or donation \<12 weeks prior to investigation
• •Active chemotherapy
• •Inability to follow the procedures of the investigation, e.g. due to language problems, psychological disorders, dementia, etc. of the subject.
• •Note
• •Due to slow recruitment, the following inclusion criterion was removed on 09/25/2024 (MM/DD/YYYY):
• •Anemia (as defined by the WHO): Hemoglobin \<130 g/L for men, Hemoglobin \<120 g/l for women, Hemoglobin \<110 g/l for pregnant women